Phase III randomised, placebo-controlled, double-blind, multicentre, clinical trial to determine the efficacyand safety of Presendin in idiopathic intracranial hypertension

Project: Research project

Project Details

Description

Phase III randomised, placebo-controlled, double-blind, multicentre, clinical trial to determine the efficacy and safety of Presendin in idiopathic intracranial hypertension
StatusActive
Effective start/end date2/27/2312/31/24

Funding

  • INVEX THERAPEUTICS

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.